Learn about the clinical implications of rheumatoid factor positivity in psoriatic arthritis and its effect on biologic therapy discontinuation.
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Smart PSA boosted targeted screening and found more aggressive prostate cancers in Black men in Chicago trials.
Patients with advanced prostate cancer may need periodic imaging scans to catch tumor growth even with stable levels of ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
A 74-year-old man with an active lifestyle and no family history of prostate cancer presented with mild urinary hesitancy and ...
Indications now include pediatric plaque psoriasis and active PsA starting at age 6, positioning risankizumab as the first US-approved IL-23(p19) inhibitor for <40 kg pediatric patients. Weight-tiered ...
Lupin Limited has received tentative approval from the FDA for its abbreviated new drug application (ANDA) for enzalutamide ...
Bob covers the money in health care, focusing on health insurance and hospitals. His stories delve into Medicare Advantage, opaque prescription drug benefits, and how much executives actually make. He ...
Humira (adalimumab) is used to treat several autoimmune conditions. The drug typically stays in your system for a few months after your final dose. This article explains how long Humira may remain in ...
PSA is making it a smooth transition to turn your graded cards into cash. The top grading company in the industry has created a new program, called PSA Offers, which gives customers the option of ...
Cosentyx (secukinumab) and Humira (adalimumab) are prescription drugs used to treat similar conditions. Both drugs come as subcutaneous injections, however, Cosentyx may also be given as an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results